Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»HealthCare»TransCanna Will Acquire Daily Cannabis Goods Brand with GoodFellas Acquisition
    HealthCare

    TransCanna Will Acquire Daily Cannabis Goods Brand with GoodFellas Acquisition

    Marie JonesBy Marie JonesApril 23, 2019Updated:April 24, 2019No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Vancouver, BC – (ACN Newswire) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) announces that the acquisition of GoodFellas will result in acquiring an additional existing brand called Daily Cannabis Goods (“Daily”). The Daily brand consists of three quality half gram pre-rolls which are attractively packaged and priced.

    “The Daily brand is a perfect fit for TransCanna,” Stated Jim Pakulis, CEO of TransCanna. “The start-up costs were nominal, it has SKU velocity now that it’s selling in over thirty dispensaries, and it’s constantly beating the competition due to consumer demand.”

    “The Daily brand has seen a steady consistent increase in sales since it commenced in August 2018. The first month shipments of units exceeded 2,100 and by December the number of units shipped for the month exceed 10,000. We anticipate closing the acquisition of GoodFellas by May 20th, and then we’ll budget accordingly in order to work on increasing units sold.”

    Subsequent to the acquisition, TransCanna anticipates expanding the Daily line to include three additional SKU’s.

    For further information, please visit the Company’s website at www.transcanna.com.

    About TransCanna Holdings Inc.
    TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

    For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

    Media Contact
    TransCanna@talkshopmedia.com
    604-738-2220

    On behalf of the Board of Directors
    James Pakulis
    Chief Executive Officer
    Telephone: (604) 609-6199

    The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise. Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. 

    Canada TransCanna Holdings Inc.
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleNetwork International and JCB enable JCB Contactless acceptance in the United Arab Emirates
    Next Article Trintech Adds Over 20 Industry-Leading Capabilities to Cadency’s Transformative System of Controls for the Office of Finance

    Related Posts

    ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801’s Renoprotective Potential in Oral Presentation

    June 5, 2026

    Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

    June 4, 2026

    Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion

    June 4, 2026
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.